Cystic Fibrosis Research for CFTR Modulator Response
Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients
- Sex
- Any
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 75 (estimated)
- Sponsor
- Hôpital Necker-Enfants Malades · Other
This trial is looking for cystic fibrosis patients to help understand how well certain biological markers can predict responses to treatments. Participants may or may not be currently treated with CFTR modulators.
You may be able to join if
- I have cystic fibrosis and am treated with a CFTR modulator
- I have cystic fibrosis and am not treated with a CFTR modulator
- I have a suspected diagnosis of cystic fibrosis but tests ruled it out
You may not be able to join if
- I am pregnant or breastfeeding
- I cannot have a nasal swab
- I cannot have a rectal biopsy
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe purpose of this study is to determine which biological marker, or association of biological markers, best predict clinical response of cystic fibrosis patients to CFTR modulators.
Loading trial locations…